Exploration of SARS-CoV-2 3CLpro Inhibitors by Virtual Screening Methods, FRET Detection, and CPE Assay-Reference-Cited by-同舟云学术

Exploration of SARS-CoV-2 3CLpro Inhibitors by Virtual Screening Methods, FRET Detection, and CPE Assay

Published:2021-11-19 Issue:12 Volume:61 Page:5763-5773
ISSN:1549-9596
Container-title:Journal of Chemical Information and Modeling
language:en
Short-container-title:J. Chem. Inf. Model.

Author:

Zhao Jun¹,Ma Qinhai²,Zhang Baoyue¹,Guo Pengfei¹,Wang Zhe¹,Liu Yi³,Meng Minsi³,Liu Ailin¹,Yang Zifeng²,Du Guanhua¹

Affiliation:

1. Beijing Key Lab of Drug Target Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China

2. State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510000, China

3. College of Chemical Engineering, Sichuan University of Science & Engineering, 519 Huixing Road, Zigong, Sichuan 643000, China

Funder

National Natural Science Foundation of China

Drug Innovation Major Project

CAMS Major collaborative innovation fund for major frontier research

Publisher

American Chemical Society (ACS)

Subject

Library and Information Sciences,Computer Science Applications,General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jcim.1c01089

Reference23 articles.

1. World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard[EB/OL]. https://covid19.who.int/ (accessed March 3, 2021).

2. World Health Organization. Draft Landscape of COVID 19 Candidate Vaccines[EB/OL]. https://www.who.int/who-documents-detail/draft-landscape-of-covid-19-candidate-vaccines (accessed March 3, 2021).

3. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

4. World Health Organization. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19─25 May 2020[EB/OL], 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-25-may-2020.

5. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of novel human neutrophil elastase inhibitors from natural compounds: Virtual screening, in vitro, molecular dynamics simulation and in vivo study;European Journal of Pharmacology;2024-11

2. Natural 7,8-secolignans from Schisandra sphenanthera fruit potently inhibit SARS-CoV-2 3CLpro and inflammation;Journal of Traditional and Complementary Medicine;2024-09

3. A novel ultrasonic-assisted technique for eco-friendly extraction of oligostilbenes from the Paeonia delavayi seed coat and the inhibition on 3 C-like protease;Industrial Crops and Products;2024-07

4. Correction to “Exploration of SARS-CoV-2 3CL^pro Inhibitors by Virtual Screening Methods, FRET Detection, and CPE Assay”;Journal of Chemical Information and Modeling;2024-05-07

5. Stand Up to Stand Out: Natural Dietary Polyphenols Curcumin, Resveratrol, and Gossypol as Potential Therapeutic Candidates against Severe Acute Respiratory Syndrome Coronavirus 2 Infection;Nutrients;2023-09-06